Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 4 studies | 23% ± 2% | |
non-classical monocyte | 4 studies | 18% ± 1% | |
monocyte | 3 studies | 29% ± 11% | |
microglial cell | 3 studies | 41% ± 13% | |
macrophage | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of FCGR1BP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 78% | 82.30 | 2053 / 2642 | 83% | 3.28 | 585 / 705 |
lung | 96% | 100.98 | 555 / 578 | 27% | 0.45 | 307 / 1155 |
thymus | 98% | 94.70 | 642 / 653 | 20% | 0.33 | 124 / 605 |
spleen | 99% | 261.12 | 238 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 89% | 66.59 | 230 / 258 | 7% | 0.14 | 17 / 230 |
kidney | 57% | 23.99 | 51 / 89 | 34% | 0.67 | 302 / 901 |
peripheral blood | 81% | 888.28 | 753 / 929 | 0% | 0 | 0 / 0 |
adipose | 72% | 50.31 | 865 / 1204 | 0% | 0 | 0 / 0 |
breast | 44% | 18.70 | 201 / 459 | 26% | 0.42 | 293 / 1118 |
blood vessel | 69% | 50.39 | 925 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 2.52 | 19 / 29 |
stomach | 55% | 21.81 | 198 / 359 | 9% | 0.14 | 27 / 286 |
bladder | 52% | 23.81 | 11 / 21 | 11% | 0.24 | 55 / 504 |
prostate | 58% | 24.37 | 141 / 245 | 1% | 0.01 | 3 / 502 |
ovary | 37% | 10.51 | 66 / 180 | 20% | 0.32 | 87 / 430 |
uterus | 35% | 10.57 | 59 / 170 | 14% | 0.26 | 64 / 459 |
pancreas | 32% | 10.58 | 105 / 328 | 10% | 0.15 | 18 / 178 |
intestine | 36% | 14.37 | 344 / 966 | 4% | 0.06 | 22 / 527 |
heart | 38% | 15.56 | 328 / 861 | 0% | 0 | 0 / 0 |
liver | 34% | 13.54 | 77 / 226 | 3% | 0.09 | 13 / 406 |
skin | 6% | 1.61 | 110 / 1809 | 31% | 0.68 | 144 / 472 |
esophagus | 24% | 8.87 | 348 / 1445 | 3% | 0.05 | 5 / 183 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.16 | 4 / 45 |
eye | 0% | 0 | 0 / 0 | 5% | 0.08 | 4 / 80 |
muscle | 3% | 0.78 | 25 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0001788 | Biological process | antibody-dependent cellular cytotoxicity |
GO_0038094 | Biological process | Fc-gamma receptor signaling pathway |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0031901 | Cellular component | early endosome membrane |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0030669 | Cellular component | clathrin-coated endocytic vesicle membrane |
GO_0019864 | Molecular function | IgG binding |
GO_0019763 | Molecular function | immunoglobulin receptor activity |
GO_0019770 | Molecular function | IgG receptor activity |
Gene name | FCGR1BP |
Protein name | Putative high affinity immunoglobulin gamma Fc receptor IB (IgG Fc receptor IB) (Fc gamma receptor IB pseudogene) (Fc-gamma RIB) (FcRIB) (hFcgammaRIB) |
Synonyms | FCGR1B IGFRB |
Description | FUNCTION: May bind to the Fc region of immunoglobulins gamma with a low affinity compared to FCGR1A. May function in the humoral immune response. . |
Accessions | Q92637 |